The leading CEO forum for pharmaceutical producers, distributors and retailers in Russia

12 - 13 May 2021

Corinthia Saint-Petersburg Hotel

THE MOST IMPORTANT PHARMA EVENT IN RUSSIA IN 2021

The key event for the pharmaceutical industry, the 27th annual RUSSIAN PHARMACEUTICAL FORUM 2021 will take place on 12-13 May 2021 at our traditional venue, the Corinthia Hotel in SAINT PETERSBURG, as well as in  live ONLINE format. 
Join us at this meeting of the key international and Russian pharmaceutical industry experts! 

HYBRID FORMAT – MEET YOUR COLLEAGUES FACE-TO-FACE AND ONLINE


Meet new partners and network with the leading players on the pharmaceutical market – both in person in SAINT PETERSBURG (places strictly limited!), or via our online event platform, using live online chat, emails and video calls! 
If you are unable to join us in-person in St. Petersburg, you can connect to the event from your laptop, tablet or mobile phone – so you can save time travelling and maximise time learning from experts and engaging with speakers and other delegates. 

Speakers 2021

Elena Kartasheva, President, Takeda
Elena Kartasheva

President

Takeda

Ekaterina Pogodina, Managing Director, Russia & CIS, Johnson & Johnson
Ekaterina Pogodina

Managing Director, Russia & CIS

Johnson & Johnson

Stephan Eder, Executive Vice President, Russia and CIS, STADA
Stephan Eder

Executive Vice President, Russia and CIS

STADA

Oxana Monge, General Director, Eurasia, Sanofi
Oxana Monge

General Director, Eurasia

Sanofi

Vasily Ignatiev, General Director, R-Pharm
Vasily Ignatiev

General Director

R-Pharm

Dmitriy Morozov, Chairman of the Board of Directors, Biocad
Dmitriy Morozov

Chairman of the Board of Directors

Biocad

Matthias Wernicke, Managing Director, Russia and CIS, Merck
Matthias Wernicke

Managing Director, Russia and CIS

Merck

Dmitry Rozhdestvensky, Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation, Eurasian Economic Commission
Dmitry Rozhdestvensky

Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation

Eurasian Economic Commission

Adlane Soudani, General Manager, Ipsen
Adlane Soudani

General Manager

Ipsen

Peter Rodionov*, General Manager, Geropharm
Peter Rodionov*

General Manager

Geropharm

Dmitry Pogrebinsky, General Director, Protek
Dmitry Pogrebinsky

General Director

Protek

Elena Litvinova, General Director, NovaMedica
Elena Litvinova

General Director

NovaMedica

Alexander Kuzin, General Director, Pharmacy Chain 36.6
Alexander Kuzin

General Director

Pharmacy Chain 36.6

Yury Krestinskiy, Chairman of the Expert Board, Institute of Public Healthcare Development
Yury Krestinskiy

Chairman of the Expert Board

Institute of Public Healthcare Development

Oxana Kudelya, Market Access, Pricing and Commercial Director, Russia & CIS, Merck
Oxana Kudelya

Market Access, Pricing and Commercial Director, Russia & CIS

Merck

Maxim Stetsyuk, Executive Director, member of the Management Board, Nanolek
Maxim Stetsyuk

Executive Director, member of the Management Board

Nanolek

Rustam Iksanov, Vice President, R&D, NovaMedica
Rustam Iksanov

Vice President, R&D

NovaMedica

Vladimir Shipkov, Executive Director, AIPM Russia
Vladimir Shipkov

Executive Director

AIPM Russia

Alexei Shavenzov*, GA&P Senior Director Russia & CIS, Johnson & Johnson
Alexei Shavenzov*

GA&P Senior Director Russia & CIS

Johnson & Johnson

Alexander Rudko, General Director, R&D-centre NovaMedica Innotech
Alexander Rudko

General Director

R&D-centre NovaMedica Innotech

Egor Zhavoronkov, Head of 'Pharma group', CRPT
Egor Zhavoronkov

Head of 'Pharma group'

CRPT

Vadim Kukava, Executive Director, Association of Pharmaceutical Companies “Innovative Pharma”
Vadim Kukava

Executive Director

Association of Pharmaceutical Companies “Innovative Pharma”

Evgeny Barinov, DEPUTY GENERAL DIRECTOR, CHIEF INVESTMENT AND DIGITAL OFFICER, Nanolek
Evgeny Barinov

DEPUTY GENERAL DIRECTOR, CHIEF INVESTMENT AND DIGITAL OFFICER

Nanolek

Marina Mazurevskaya, DEPUTY GENERAL DIRECTOR, LEGAL & GOVERNMENTAL RELATIONS AFFAIRS, Nanolek
Marina Mazurevskaya

DEPUTY GENERAL DIRECTOR, LEGAL & GOVERNMENTAL RELATIONS AFFAIRS

Nanolek

Vera Emelyanova, Medical Director, Ipsen
Vera Emelyanova

Medical Director

Ipsen

Anastasiya Chernousova, Head of Consumer Healthcare, Ipsen
Anastasiya Chernousova

Head of Consumer Healthcare

Ipsen

David Pérez Godia, Supply Chain Manager, Merck Biopharma в России и СНГ
David Pérez Godia

Supply Chain Manager

Merck Biopharma в России и СНГ

Olivier Simonnot, Senior Manager, Strategic Marketing Life Sciences EMEA, Sensitech
Olivier Simonnot

Senior Manager, Strategic Marketing Life Sciences EMEA

Sensitech

Viktor Dmitriev, General Director, Association of Russian Pharmaceutical Manufacturers
Viktor Dmitriev

General Director

Association of Russian Pharmaceutical Manufacturers

Nikita Ivanov, Senior Director, Corporate Affairs, Health & Value (Market Access), Business Development, Pfizer
Nikita Ivanov

Senior Director, Corporate Affairs, Health & Value (Market Access), Business Development

Pfizer

Alexey Migulin, Market Access Director, Russia and Belarus, Pfizer
Alexey Migulin

Market Access Director, Russia and Belarus

Pfizer

Nikolay Sonichev, Rare Disease commercial lead , Pfizer Russia & Belarus
Nikolay Sonichev

Rare Disease commercial lead

Pfizer Russia & Belarus

Mariya Burchakova, Market Access and Public Affairs Director, Russia & CIS, Ipsen
Mariya Burchakova

Market Access and Public Affairs Director, Russia & CIS

Ipsen

Igor Bakhmetiev, Commercial Director, Russia and CIS, STADA
Igor Bakhmetiev

Commercial Director, Russia and CIS

STADA

Stanislav Naumov, General Manager, Eurasian centre of intergrational research and communication
Stanislav Naumov

General Manager

Eurasian centre of intergrational research and communication

Ekaterina Creanga, General Manager, LifeScan
Ekaterina Creanga

General Manager

LifeScan

Evgeny Korotkov, General Director, Proapteka
Evgeny Korotkov

General Director

Proapteka

Boris Popov, Commercial Director, CV Protek
Boris Popov

Commercial Director

CV Protek

Nelly Ignatieva, Executive Director, Russian Association of Pharmacy Chains
Nelly Ignatieva

Executive Director

Russian Association of Pharmacy Chains

Viktoria Presnyakova, Director, Association of indpedent pharmacies
Viktoria Presnyakova

Director

Association of indpedent pharmacies

Alexey Konov, Founder, Managing Partner            , RBV Capital
Alexey Konov

Founder, Managing Partner

RBV Capital

Alexander Shishkin, General Director, Pharmacy Chain ASNA
Alexander Shishkin

General Director

Pharmacy Chain ASNA

Natalya Petlyuk, Eyecare department Managing Director, Alcon Russia
Natalya Petlyuk

Eyecare department Managing Director

Alcon Russia

Alexander Kotlyarov, Project Manager, vseapteki.ru , Mail.Ru Group
Alexander Kotlyarov

Project Manager, vseapteki.ru

Mail.Ru Group

Vladimir Nesterenko, Managing Director, GDP
Vladimir Nesterenko

Managing Director

GDP

Mikhail Khazanchuk Chair of Industry policy committee, Chair of Industry policy committee, AIPM
Mikhail Khazanchuk Chair of Industry policy committee

Chair of Industry policy committee

AIPM

Vitaly Dembrovskiy, Market Access Director, Russia and Eurasia, AstraZeneca
Vitaly Dembrovskiy

Market Access Director, Russia and Eurasia

AstraZeneca

Natalia Polushkina, Vice President, Biomedical Cluster, Skolkovo
Natalia Polushkina

Vice President, Biomedical Cluster

Skolkovo

Airat Farrahov, State Duma Deputy, The State Duma
Airat Farrahov

State Duma Deputy

The State Duma

Maria Lituchaya, General Manager, Russia & CIS, CSL Behring
Maria Lituchaya

General Manager, Russia & CIS

CSL Behring

Alexander Filippov, General Director, Rigla
Alexander Filippov

General Director

Rigla

Elena Popova, Senior Director Regulatory Affairs & Healthcare Policy, AIPM Russia
Elena Popova

Senior Director Regulatory Affairs & Healthcare Policy

AIPM Russia

Nikolay Lyskov, Head of the Department of Chemistry, Biotechnology and Medicine, Federal Institute of Industrial Property
Nikolay Lyskov

Head of the Department of Chemistry, Biotechnology and Medicine

Federal Institute of Industrial Property

Alexandr Sokolov, Key Account Director, Teva
Alexandr Sokolov

Key Account Director

Teva

Andrey Kolesnikov, Senior Director Government Affairs & Market Access, Russia and Eurasia , Teva
Andrey Kolesnikov

Senior Director Government Affairs & Market Access, Russia and Eurasia

Teva

Margarita Mustafina, Quality Director, Russia and Eurasia, Teva
Margarita Mustafina

Quality Director, Russia and Eurasia

Teva

Dmitry Koloda, Medical Director, CIS, Takeda Pharmaceuticals
Dmitry Koloda

Medical Director, CIS

Takeda Pharmaceuticals

Irina Ivanishcheva, Director of Legal Department, AstraZeneca Russia & Eurasia
Irina Ivanishcheva

Director of Legal Department

AstraZeneca Russia & Eurasia

Interview with Alexey Savin – Regional Principal, Eastern Europe, Russia & CIS – IQVIA 

Key topics at the Russian Pharmaceutical Forum 2021:

The Russian Pharma Forum is an annual meeting place, the main platform for active and productive dialogue between all the principal stakeholders in the Russian pharmaceutical market. What questions will be discussed in 2021? 
 
 
REGULATION OF THE SECTOR

  • How has the pandemic affected the pharma regulatory landscape?
  • Upcoming regulatory changes: what is important to know? 
     
     
    PRODUCTION
  • Establishing new strategic partnerships with the leading international producers
  • Production localisation and technology transfer of breakthrough drugs
  • Development of active pharmaceutical substance production in Russia 
     
     
    DISTRIBUTION
  • Evolution of the wholesale segment and pharmaceutical logistics
  • Examples of new technologies in product distribution management
  • Vertical integration – a new model of development for distribution businesses 
     
     
    RETAIL
  • Development of the distance retail model for pharmaceutical products in Russia
  • Challenges of implementing new methods of medical product delivery
  • New kinds of competition and cooperation: pharma aggregators and marketplaces 
     
     
    TECHNOLOGY
  • Integration of advanced production and research technologies and processes
  • How to ensure consistent international quality standards  in drug manufacturing
  • Big data in the pharmaceutical industry: from RWE to sales. Myths and reality 
     
     
    INNOVATION
  • Development and market launch of new highly effective therapies in Russia
  • Local research and development and products for treating complex diseases
  • Lessons of COVID-19: breakthroughs in immunology, investment into vaccine development  
     
     
    PATIENTS
  • How to make modern medical treatments highly accessible to patients?
  • Paradigm shift – what is a socially responsible pharmaceutical business?
  • What are the obstacles to successfully implementing a patient-oriented approach to healthcare? 
     
     
    HEALTHCARE
  • Integrated solutions for the digital transformation of the healthcare system 
  • Pharmaceutical industry and primary healthcare modernisation programme in Russia
  • The role of pharmaceutical companies in expanding access to quality healthcare 
     
     
    SALES AND PROMOTION
  • How to still survive and thrive when customer buying- power is reduced?
  • What does an effective marketing strategy look like in the post-Covid era l?
  • Market-leading case studies of digital visits by medical representatives 
     
    ANALYTICS
  • Overview of the current state of the market and forecasts for future developments in Russia
  • Which strategic directions should you prioritise and invest in today? 
    Competition on the Russian pharmaceutical market – leaders and new players 

Pharma versus coronavirus: interviews with General Directors 

General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19. 

The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products. 

The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation. 

 

READ OUR PHRAMACEUTICAL BLOG>>

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA

RUSSIAN PHARMACEUTICAL FORUM ATTENDEES INCLUDE:

Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare

Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals

Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences

WHY TO ATTEND THE RUSSIAN PHARMACEUTICAL FORUM?

russianpharma 023

27 years in the market! Russia's longest-running pharmaceutical forum

russianpharma 018

The highest profile executive-level speakers and attendees

russianpharma 150

Unrivalled networking opportunities - meet key decision makers